It’s easy to view cognitive decline as an inevitable slide that we are powerless to fight. But knowing the early signs - beyond short-term memory loss and trouble word-finding - could really make a di ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...

Jeff Bridges has lost his family's Malibu home to the wildfires that have been ravaging Los Angeles.  The property was passed ...

A novel tool known as the Florey Dementia Index (FDI) predicted onset age of mild cognitive impairment or Alzheimer's disease ...

The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...

Tufts and Oxford researchers found that head trauma reactivates HSV-1 in the brain, leading to neurodegeneration linked to ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems long and uncertain, according to a news release.

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...